AKT1 and non-small cell lung carcinoma: Recent studies have shown that fluorofenidone (AKF-PD) significantly inhibits NSCLC cell proliferation and invasion, suppresses MAPK and PI3K/AKT/mTOR signalling, and reverses EMT.